Case Overview
Search Import Questions Import Conditions Onshore Outcomes
Case: Dietary supplements and natural medicines of plant origin for human consumption Effective 07 Jan 2023 to 26 Jan 2023
Case Description
This case describes the requirements for the importation of dietary supplements and natural medicines of plant origin for human consumption.
For human therapeutics and medicines containing biological material of animal or microbial please refer to the BICON case Human therapeutics and medicines.
For protein powders and supplements (e.g. performance enhancement supplements), please refer to the BICON case Protein powders and body building supplements for human consumption.
For products containing mushrooms please refer to the BICON case Mushrooms for human consumption.
For products containing seaweed please see the BICON case Seaweed.
This case applies to imports into: Australia.
- Case options
- Follow case
- Bookmark options
- Email current scenario
- Save / Print
- Case details
- Overview
- Appendices
- Alerts
- Changes
- History
- Risk backgrounds